Benitec Biopharma Stock Price, News & Analysis (NASDAQ:BNTC)

$2.94 -0.17 (-5.47 %)
(As of 12/13/2017 06:09 AM ET)
Previous Close$3.11
Today's Range$2.86 - $3.18
52-Week Range$1.30 - $5.48
Volume20,800 shs
Average Volume287,413 shs
Market Capitalization$31.90 million
P/E RatioN/A
Dividend YieldN/A
Beta3.63

About Benitec Biopharma (NASDAQ:BNTC)

Benitec Biopharma Limited is a biotechnology company. The Company is engaged in progressing programs through the clinic; the commercialization of its Intellectual Property (IP); development of its therapeutic pipeline and pre-clinical programs, and funding, and protecting and building the IP estate. Its In-house product candidates include TT-034, BB-HB-331, BB-AMD-211 and ddRNAi therapeutic. It is focused on commercialization by licensing and partnering of patents and licenses in biotechnology, in functional genomics, with applications in biomedical research and human therapeutics. It has a pipeline of in-house and partnered therapeutic programs based on its patented gene-silencing technology, deoxyribonucleic acid (DNA)-directed ribonucleic acid interference (ddRNAi). The Company is engaged in developing treatments for chronic human conditions, such as hepatitis B, wet age-related macular degeneration (AMD), and oculopharyngeal muscular dystrophy (OPMD) based on this technology.

Receive BNTC News and Ratings via Email

Sign-up to receive the latest news and ratings for BNTC and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Biotechnology & Medical Research
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:BNTC
CUSIPN/A
Phone61-2-9555-6986

Debt

Debt-to-Equity RatioN/A
Current Ratio11.80%
Quick Ratio11.80%

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$8.36 million
Price / Sales3.61
Cash FlowN/A
Price / CashN/A
Book Value$1.58 per share
Price / Book1.86

Profitability

Trailing EPS($0.79)
Net Income$-4,280,000.00
Net Margins-151.05%
Return on Equity-45.00%
Return on Assets-42.21%

Miscellaneous

Employees18
Outstanding Shares10,260,000

Benitec Biopharma (NASDAQ:BNTC) Frequently Asked Questions

What is Benitec Biopharma's stock symbol?

Benitec Biopharma trades on the NASDAQ under the ticker symbol "BNTC."

When will Benitec Biopharma make its next earnings announcement?

Benitec Biopharma is scheduled to release their next quarterly earnings announcement on Thursday, February, 22nd 2018. View Earnings Estimates for Benitec Biopharma.

Who are some of Benitec Biopharma's key competitors?

Who are Benitec Biopharma's key executives?

Benitec Biopharma's management team includes the folowing people:

  • Gregory West, Chief Executive Officer, Company Secretary
  • Bryan Dulhunty, Chief Financial Officer
  • Clifford Michael Holloway, Chief Business and Operating Officer (Age 57)
  • Michael Graham, Chief Scientific Officer
  • Jerel A. Banks M.D., Ph.D., Non-Executive Chairman of the Board
  • Kevin Buchi CPA, Director
  • Megan Joan Boston, Non-Executive Director
  • Peter Damian Francis, Non-Executive Director

When did Benitec Biopharma IPO?

(BNTC) raised $0 in an IPO on Thursday, August 6th 2015. The company issued 0 shares at $0.00 per share. BMO Capital Markets and Maxim Group LLC served as the underwriters for the IPO and Roth Capital Partners was co-manager.

How do I buy Benitec Biopharma stock?

Shares of Benitec Biopharma can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Benitec Biopharma's stock price today?

One share of Benitec Biopharma stock can currently be purchased for approximately $2.94.

How big of a company is Benitec Biopharma?

Benitec Biopharma has a market capitalization of $31.90 million and generates $8.36 million in revenue each year. The biotechnology company earns $-4,280,000.00 in net income (profit) each year or ($0.79) on an earnings per share basis. Benitec Biopharma employs 18 workers across the globe.

How can I contact Benitec Biopharma?

Benitec Biopharma's mailing address is 99 Mount Street Suite 1201, Sydney C3, 2060. The biotechnology company can be reached via phone at 61-2-9555-6986 or via email at [email protected]


MarketBeat Community Rating for Benitec Biopharma (BNTC)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  40 (Vote Outperform)
Underperform Votes:  40 (Vote Underperform)
Total Votes:  80
MarketBeat's community ratings are surveys of what our community members think about Benitec Biopharma and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Benitec Biopharma (NASDAQ:BNTC) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.002.002.002.00
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: N/AN/AN/A$14.00
Price Target Upside: N/AN/AN/A527.80% upside

Benitec Biopharma (NASDAQ:BNTC) Consensus Price Target History

Price Target History for Benitec Biopharma (NASDAQ:BNTC)

Benitec Biopharma (NASDAQ:BNTC) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
8/30/2017Maxim GroupReiterated RatingHoldMediumView Rating Details
(Data available from 12/13/2015 forward)

Earnings

Earnings History for Benitec Biopharma (NASDAQ:BNTC)


No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Benitec Biopharma (NASDAQ:BNTC) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Benitec Biopharma (NASDAQ:BNTC)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Benitec Biopharma (NASDAQ BNTC)

No insider trades for this company have been tracked by MarketBeat.com

Headlines

Benitec Biopharma (NASDAQ BNTC) News Headlines

Source:
DateHeadline
Benitec Biopharma (BNTC) Downgraded to Sell at ValuEngineBenitec Biopharma (BNTC) Downgraded to Sell at ValuEngine
www.americanbankingnews.com - December 3 at 9:26 PM
Benitec Biopharma provides update on OPMD orphan disease programBenitec Biopharma provides update on OPMD orphan disease program
finance.yahoo.com - November 27 at 6:30 PM
U.S. patent granted for Benitec hepatitis B programU.S. patent granted for Benitec hepatitis B program
finance.yahoo.com - October 18 at 5:59 PM
Benitec Biopharma Ltd. :BNTC-US: Earnings Analysis: For the six months ended June 30, 2017 : September 5, 2017Benitec Biopharma Ltd. :BNTC-US: Earnings Analysis: For the six months ended June 30, 2017 : September 5, 2017
finance.yahoo.com - September 5 at 6:16 PM
Benitec Biopharma Ltd. :BNTC-US: Earnings Analysis: 2017 By the Numbers : September 1, 2017Benitec Biopharma Ltd. :BNTC-US: Earnings Analysis: 2017 By the Numbers : September 1, 2017
finance.yahoo.com - September 1 at 4:55 PM
Benitec Biopharma Limited (BNTC) Earns "Hold" Rating from Maxim GroupBenitec Biopharma Limited (BNTC) Earns "Hold" Rating from Maxim Group
www.americanbankingnews.com - August 30 at 11:20 AM
Benitec Biopharma advances OPMD orphan disease programBenitec Biopharma advances OPMD orphan disease program
finance.yahoo.com - August 8 at 4:23 PM
Mid-Day Market Update: Shutterfly Drops On Downbeat Earnings; Mead Johnson Shares Spike HigherMid-Day Market Update: Shutterfly Drops On Downbeat Earnings; Mead Johnson Shares Spike Higher
www.benzinga.com - February 2 at 9:14 PM
Mid-Afternoon Market Update: Weatherford Rises Following Q4 Results; Ralph Lauren Shares PlungeMid-Afternoon Market Update: Weatherford Rises Following Q4 Results; Ralph Lauren Shares Plunge
www.nasdaq.com - February 2 at 4:09 PM
Benitec Biopharma (BNTC) Gains After Announces Progress on ddRNAi TechnologyBenitec Biopharma (BNTC) Gains After Announces Progress on ddRNAi Technology
www.streetinsider.com - February 2 at 4:09 PM
Tuesday’s Top Biopharma MoversTuesday’s Top Biopharma Movers
247wallst.com - January 19 at 5:03 PM
Benitec Biopharma (BNTC) Leaped After European Orphan Drug DesignationBenitec Biopharma (BNTC) Leaped After European Orphan Drug Designation
www.rttnews.com - January 19 at 5:03 PM
Benitec Receives Orphan Drug Designation in the...Benitec Receives Orphan Drug Designation in the...
www.benzinga.com - January 18 at 3:24 PM
Benitec Biopharma (BNTC) BB-301 Granted Orphan Drug Designation in EUBenitec Biopharma (BNTC) BB-301 Granted Orphan Drug Designation in EU
www.streetinsider.com - January 18 at 3:24 PM
Benitec Receives Orphan Drug Designation in the European Union for BB-301, a ddRNAi Therapeutic in Development for the Treatment of Oculopharyngeal Muscular DystrophyBenitec Receives Orphan Drug Designation in the European Union for BB-301, a ddRNAi Therapeutic in Development for the Treatment of Oculopharyngeal Muscular Dystrophy
us.rd.yahoo.com - January 17 at 9:32 AM
Benitec in-licenses clinical program for head and neck cancer from NantWorksBenitec in-licenses clinical program for head and neck cancer from NantWorks
us.rd.yahoo.com - December 23 at 4:07 PM
7:13 am Benitec Biopharma in-licenses clinical program for head and neck cancer from NantWorks; financial terms not disclosed7:13 am Benitec Biopharma in-licenses clinical program for head and neck cancer from NantWorks; financial terms not disclosed
us.rd.yahoo.com - December 23 at 4:07 PM

SEC Filings

Benitec Biopharma (NASDAQ:BNTC) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

Benitec Biopharma (NASDAQ BNTC) Stock Chart for Wednesday, December, 13, 2017

Loading chart…

This page was last updated on 12/13/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.